InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: chickpea598 post# 35033

Thursday, 04/14/2016 1:31:41 PM

Thursday, April 14, 2016 1:31:41 PM

Post# of 48316
Merck may pursue combo for H&N in the near future. The FDA accepted an sBLA from Merck for Keytruda yesterday actually.

http://www.businesswire.com/news/home/20160413005160/en/FDA-Accepts-Supplemental-Biologics-License-Application-sBLA

I really hope ONCS can prove efficacy on Melanoma combo with a bang so that it can bargain a nice premium for other indications, including potential new ones that are hard to reach, for which they have the "go anywhere device" in R&D at the moment.